Trial NCT04525391

View at ClinicalTrials.gov 
Org. Study IDs: SUKSES-N5

Last trial update was posted on 2022-02-25

MeSH Interventions

Durvalumab

MeSH Conditions

Small Cell Lung Carcinoma

Other Conditions

SCLC, Recurrent

Stopping Reasons

Recommended completion of the study due to SUSAR occurring in other clinical trials conducted with the same drug.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID